 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
  |
 |
||||||||||||||||||||||||||||||||||||||
 |
Medical Board
|
|||||||||||||||||||||||||||||||||||||
| Name | `Institution | Field of Interest |
| Phyllis August | Cornell University | nephrology |
| *Thomas Easterling | University of Washington | hemodynamics |
| Marshall Lindheimer | University of Chicago | nephrology |
| James Martin | University of Mississippi | HELLP Syndrome |
| John T. Repke | Penn State College of Medicine | Preeclampsia Prevention; Calcium metabolism |
| James Roberts | Magee Women's | endothelial cells |
| Baha Sibai | University of Cincinnati | HELLP Syndrome |
| Suzanne Oparil | University of Alabama School of Medicine in Birmingham | Hypertension and cardiovascular disease |
| Peter von Dadelszen | University of British Columbia | Preeclampsia Therapies |
| Ananth Karumanchi | Harvard Medical School | nephrology |
| * directorr | | |
Dr. Phyllis August
Since 1996, Dr. August has been the Chief of the Division of Hypertension,
Cardiovascular Center and a professor of medicine at Cornell University’s
Weill Medical College. A 1977 graduate of the Yale Medical School, she did
her residency in internal medicine and her fellowship in nephrology and
hypertension at the New York Hospital-Cornell Medical Center. She is also a
practicing physician who brings much clinical evidence to her study of
hypertension in pregnancy.
Back to top
Dr. Thomas R. Easterling
Dr. Easterling received his MD from
University of North Carolina Medical School. He is a national expert in the
field of hypertension in pregnancy. A professor at the University of
Washington Medical School joining the staff in 1985, Dr. Easterling has
received numerous awards including: the Young Investigator's Award of the
International Society for the Study of Hypertension in Pregnancy, the
Society Award for the Society of Perinatal Obstetricians for research on the
hemodynamics of preeclampsia, and was honored by the journal Obstetrics &
Gynecology for conducting one of the four most significant studies of 1999
regarding early antihypertensive treatment to prevent preeclampsia. He and
his team at the University of Washington are members of the NIH-sponsored
Obstetrical Pharmacological Research Unit network investigating the use of
medications in pregnancy. Dr. Easterling continues an active clinical and
research practice at the University of Washington and is a co-founder of the
Preeclampsia Foundation.
Dr. Marshall Lindheimer
Dr Lindheimer, a board certified internist and nephrologist, is a Professor emeritus in the departments of medicine and obstetrics and gynecology at the University of Chicago, where he currently chairs the advisory board of its NIH-funded General Clinical Research Center. His clinical interests focus on the management of pregnant women with kidney disease and hypertension, while his research career has stressed renal physiology, volume homeostasis, and blood pressure control in normal and abnormal pregnancy. He is also a consultant to the World Health Organization participating in their Global Program to Conquer Preeclampsia, and advising them in the areas of clinical trials and the implementation of best care policies in developing nations. Dr Lindheimer is one of the founders of the International Society for the Study of Hypertension in Pregnancy, and has served both as its secretary-treasurer and president. His 350 plus publications include seminal basic science observations, clinical studies, numerous text chapters and author- or editorship of seven texts, including the most recent editions of Chesley's Hypertensive Disorders in Pregnancy, and Barron & Lindheimer's Medical Disorders During Pregnancy. Dr Lindheimer is a recipient of the Chesley Award for Research in Hypertension in Pregnancy.
Back to top
Dr. James M. Roberts
Dr. Roberts is Professor and Vice Chair for Research in the Department of Obstetrics, Gynecology, and Reproductive Sciences at the University of Pittsburgh School of Medicine, and Director of Magee-Womens Research Institute. Dr. Roberts has received national and international recognition for his work on preeclampsia. He was the recipient of the Chesley Award for lifetime achievement in the study of hypertension in pregnancy, is the author of more than 160 publications and is a reviewer for numerous medical and scientific journals. Other honors include election to the Institute of Medicine of the National Academy Sciences, the Alexander Award from the NICHD for career mentoring and being appointed an ad eundum member of the Royal College of Obstetrics and Gynecology. He has served on scientific review boards of the National Institutes of Health, the Medical Research Council of Canada, the Food and Drug Administration and the March of Dimes. He has held posts with the NICHD Maternal Fetal Medicine Network, the Canadian Institute of Health Sciences Research, the Perinatal Research Society, the North American Society for the Study of Hypertension in Pregnancy, the Society of Gynecological Investigation and the International Society for the Study of Hypertension in Pregnancy.
Back to top
Dr. James N. Martin, Jr.
Dr.
Martin is a professor of OBGYN, Director of the Division of Maternal-Fetal
Medicine, and Chief of Obstetrics for the Wiser Hospital for Women and
Infants at the University of Mississippi Medical Center. His clinical
expertise lies in the management of complicated pregnancies, particularly
related to hypertensive disorders. Dr. Martin is the author of more than 400
scientific communications, many which address issues related to
preeclampsia-eclampsia and atypical forms of this disease such as HELLP
syndrome. He is one of the founders and a past president of The North
American Society for the Study of Hypertension in Pregnancy, is past
president of the Society for Maternal-Fetal Medicine, and is Secretary of
ACOG National. His research in hypertensive disorders of pregnancy began
during his residency training at the University of North Carolina Hospitals
and continued while completing a fellowship in maternal-fetal medicine at
Texas Southwestern/Parkland Hospital in Dallas, Texas.
Back to top
Dr. John T. Repke
Dr. Repke
is a Professor and Chairman of the Department of Obstetrics and Gynecology
at the Penn State College of Medicine - Milton S. Hershey Medical Center. He
is a nationally recognized expert in Maternal-Fetal medicine and is listed
in "Best Doctors in America". His expertise is in the study of prevention
and management of hypertension in pregnancy and preeclampsia. In addition to
editing a textbook on Obstetrics, Dr. Repke has published over 135 research
articles in peer-reviewed journals and over 50 review articles and book
chapters. He is a Past-President of the North American Society for the Study
of Hypertension in Pregnancy. A 1974 graduate of Georgetown University, Dr.
Repke obtained his medical degree in 1978 From New York Medical College. His
internship, residency, fellowship and other professional positions have
taken him to Johns Hopkins Hospital (1978-1992), Harvard Medical
School-Brigham and Women's Hospital (1992-1998), the University of Nebraska
Medical Center, where he chaired the Department of Obstetrics and Gynecology
from 1998-2002, and to Penn State, where he has chaired the Department of
Obstetrics and Gynecology since 2002.
Back to top
Dr. Baha M. Sibai
Dr. Sibai is Professor
and Chairman of the Department of Obstetrics and Gynecology at the
University of Cincinnati College of Medicine. His academic leadership and
contributions to research, in the dissection of the hypertensive diseases of
pregnancy and other basic problems associated with obstetrics and
gynecology, has awarded him national and international recognition in the
field of Maternal-Fetal Medicine, particularly in the area of hypertension
in pregnancy. His contributions have organized the treatment plans of many
physicians. Dr. Sibai’s international notoriety in preeclampsia and
eclampsia evolved as a result of his authorship or co-authorship of over 350
peer-reviewed publications in national and internationally circulated
publications.
Back to top
Dr. Suzanne Oparil
Suzanne Oparil, MD, is Professor of Medicine and of Physiology and
Biophysics at the University of Alabama School of Medicine in Birmingham,
where she is also Director of the Vascular Biology and Hypertension Program.
Dr Oparil received her medical degree from Columbia University College of
Physicians and Surgeons in New York, New York, where she was first in her
class. She completed her residency at Columbia Presbyterian Hospital and a
fellowship at the Massachusetts General Hospital in Boston.
She is the current President of the American Society of Hypertension, a
past-President of the American Heart Association (and still an active
volunteer at both the national and affiliate levels), and the first woman
past-President of the American Federation for Medical Research. She also has
leadership roles in the Association of American Physicians, American Society
for Clinical Investigation, Southern Society for Clinical Investigation,
American Physiological Society, Clinical Physiology Advisory Committee, and
Inter-American Society of Hypertension.
Dr Oparil has a career interest in the fundamental mechanisms of
cardiovascular disease and in using the information to develop novel
treatments. Just one example is her research that led to the development of
the ACE inhibitors, the most commonly used class of drugs for the treatment
of high blood pressure and heart failure.
Dr Oparil is author and coauthor of more than 1,000 abstracts, book
chapters, and journal articles in Circulation, New England Journal of
Medicine, and American Journal of Hypertension, among others.
Back to top
Dr. Peter von Dadelszen
Peter von Dadelszen, MD, is an Assistant Professor of Obstetrics and
Gynecology (Maternal-Fetal Medicine) at the University of British Columbia
and a consulting perinatologist at Children's and Women’s Health Centre of
British Columbia (CWHCBC).
A New Zealander, Dr. von Dadelszen studied medicine at the University of
Otago, Dunedin, where he also did his postgraduate work. He continued his
specialty training in the United Kingdom, studying under Professor Chris
Redman at the Royal College of Obstetricians and Gynecologists and later in
Toronto where he completed his fellowship in maternal-fetal medicine.
His appointment at the University of British Columbia (UBC) is that of a
clinician-scientist, with 60% of his time dedicated to his research
interests in preeclampsia and pregnancy hypertension, from basic science to
clinical epidemiology. He is currently investigating the mechanisms involved
in the development of preeclampsia, as well as a possible disease-modifying
therapy.
Dr. von Dadelszen is currently the President of the North American Society
for the Study of Hypertension in Pregnancy (NASSHP) and the President of
ERIPED (Equipede Recherché Interdisciplinaire sur la Pre-Eclamspie et ses
Determinants), Canada’s preeclampsia research alliance.
Peter is married to Laura Magee, an obstetric and general internist at UBC
and CWHCBC. They share the leadership of the pregnancy hypertension research
group at CWHCBC.
Back to top
Dr. Ananth Karumanchi
S. Ananth Karumanchi is Associate Professor of Medicine at Harvard Medical
School and an attending physician in the Nephrology and Molecular and
Vascular Medicine Divisions at the Beth Israel Deaconess Medical Center. He
holds a second appointment as a Senior Scientist with the Department of
Obstetrics and Gynecology at the Beth Israel Deaconess Medical Center. He
received his M.D. from the University of Madras, Chennai, India. He is a
recipient of the Carl W. Gottschalk Research Scholar Award from the American
Society of Nephrology, the Hope Award from the Preeclampsia Foundation, the
Young Scholar Award from the American Society of Hypertension, and recently
(October, 2007) named a Howard Hughes Medical Investigator.
Medical Science and Policy Advisors
Darcy Carr, MD, University of Washington
S. Ananth Karumanchi, MD, Beth Israel Hospital
Professor J.M. Davison Royal, Victoria Infirmary, UK
Maurice Druzin, MD, Stanford University Hospital
Sig-Linda Jacobsen, MD
Oregon, Health Sciences University
Jeffrey Livingston, MD, Carilion Health Care Services, Virginia
Deborah Maine, DrPH Columbia University, Averting Maternal Death &
Disability
Christopher Redman, MA, MB, FRCP, FRCOG University of Oxford
Mike Rich, Action on Pre-Eclampsia (APEC)
Jeffrey J. Ridgeway, MD, University of Washington
Vivien Tsu, MPH, PhD Program for Appropriate Technology in Health (PATH)
Professor James Walker, St. James University Hospital, UK
Michelle A. Williams, ScD University of Washington, Seattle
Dr. Beverly Winikoff, President, Gynuity Health Projects
Andrea Camp, Senior Fellow Civil Society Institute
[Site Search] [Disclaimer] [Contact Us]
If you experience any technical problems with this website, email the Webmaster
Original Site designed by Monster Design. Original Site developed by WebMosaics.